Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
Why BioNTech Was a Sickly Stock This Week
06:50pm, Friday, 30'th Dec 2022
The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Are Investors Undervaluing BioNTech (BNTX) Right Now?
11:17am, Thursday, 29'th Dec 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
3 Big Drug, Biotech Stocks to Boost Your Portfolio in 2023
10:51am, Wednesday, 28'th Dec 2022
Here we discuss three big drug and biotech companies, Sanofi (SNY), GSK (GSK) and BioNTech (BNTX), which may prove to be good bets for your portfolio next year.
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
06:45am, Wednesday, 28'th Dec 2022
Mainz, Germany, December 28, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Prof. Ugur Sahin, M.D., will present a co
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
09:04am, Sunday, 18'th Dec 2022
Major indices such as the S&P 500 and the Nasdaq Composite may have plunged by double-digits during 2022, but certain areas of the stock market performed strongly throughout the year. One of those
Pfizer and BioNTech fast tracked by FDA for combined COVID, flu vaccine
11:49am, Friday, 16'th Dec 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss China's reopening challenges as COVID cases rise as well as the latest surrounding Pfizer and BioNTech's combined COVID and flu vaccine.
BioNTech Announces Plans for Taiwan Clinical Trial Hub
10:01am, Friday, 16'th Dec 2022
BioNTech SE (NASDAQ:BNTX) announced plans today for a clinical trial hub in Taiwan for its MRNA-based cancer immunotherapies.
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
02:43pm, Thursday, 15'th Dec 2022
Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha
All You Need to Know About BioNTech SE Sponsored ADR (BNTX) Rating Upgrade to Buy
01:33pm, Tuesday, 13'th Dec 2022
BioNTech SE Sponsored ADR (BNTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is BioNTech (BNTX) Stock Undervalued Right Now?
11:17am, Tuesday, 13'th Dec 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
FDA Approves Pfizer, Moderna's Omicron COVID Jabs in Younger Kids
12:48pm, Friday, 09'th Dec 2022
Amid a rise in seasonal respiratory illnesses in younger children across the country, the FDA broadens the label of authorized bivalent Omicron BA.4/BA.5-adapted vaccines to include children as young
Pfizer and BioNTech get FDA fast track designation for single-dose COVID and flu vaccine candidate
06:54am, Friday, 09'th Dec 2022
Pfizer Inc. PFE, +3.07% and German partner BioNTech SE BNTX, +5.64% said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccin
3 Stocks Making Big Midday Moves
03:30pm, Thursday, 08'th Dec 2022
Below we are taking a look at three popular stocks making move in today's trading, just on the heels of several earnings releases and an exciting approval from the Food & Drug Administration (FDA).
Pfizer, BioNTech ask FDA to authorize bivalent COVID vaccine in young children
11:10am, Monday, 05'th Dec 2022
Pfizer Inc. PFE, -0.77% and BioNTech SE BNTX, -1.63% said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the
